Skip to main content

Response

This is a preview of subscription content, access via your institution.

References

  • Bowman, D., & Fitzharris, M. 2007. Too small for concern? Public health and nanotechnology. Australian and New Zealand Journal of Public Health, 31(4), 382–384. doi:10.1111/j.1753-6405.2007.00092.x.

    Article  PubMed  Google Scholar 

  • European Commission. 2008. Public health (03-03-2008): Revision of risk-assessment methods needed to evaluate potential risks in the use of certain nanomaterials in cosmetic products. Brussels: EC.

    Google Scholar 

  • Faunce, T., K. Murray, H. Nasu, D.M. Bowman, et al. 2008. Sunscreen safety: The precautionary principle, the Australian Goods Administration and nanoparticles in sunscreens. NanoEthics, 2(3), forthcoming.

  • Food and Drug Administration. 2007. Nanotechnology: A report of the U.S. Food and Drug Administration nanotechnology task force p. 35. Washington DC: FDA.

    Google Scholar 

  • Friends of the Earth. 2006. Nanomaterials, sunscreens and cosmetics: Small ingredients, big risks. Sydney: Friends of the Earth Australia and Friends of the Earth United States.

    Google Scholar 

  • International Centre for Technology Assessment. 2006. Citizen petition to the United States Food and Drug Administration. Washington DC: CTA.

    Google Scholar 

  • Nohynek, G.J., Lademann, J., Ribaud, C., & Roberts, M.S. 2007. Grey goo on the skin? Nanotechnology, cosmetic and sunscreen safety. Critical Reviews in Toxicology, 37(3), 251–277. doi:10.1080/10408440601177780.

    Article  PubMed  CAS  Google Scholar 

  • Nohynek, G.J., Dufour, E.K., & Roberts, M.S. 2008. Nanotechnology, cosmetics and the skin: Is there a health risk? Skin Pharmacology and Applied Skin Physiology, 21, 136–139. doi:10.1159/000131078.

    Article  CAS  Google Scholar 

  • Scientific Committee on Consumer Products. 2005. Scientific Committee on Consumer Products (SCCP): Request for a scientific opinion: Safety of nanomaterials in cosmetic products. Brussels: Health & Consumer Protection Directorate-General.

    Google Scholar 

  • Scientific Committee on Consumer Products. 2007. Opinion on Safety of nanomaterials in cosmetic products, December. Brussels: Health & Consumer Protection Directorate-General.

    Google Scholar 

  • Swiss Re. 2004. Nanotechnology: Small matter, many unknowns. Geneva: Swiss Re.

    Google Scholar 

  • Therapeutic Goods Administration. 2003. Australian regulatory guidelines for OTC medicines. Canberra: Commonwealth Department of Health and Ageing.

    Google Scholar 

  • Therapeutic Goods Administration. 2006a. A review of the scientific literature on the safety of nanoparticulate titanium dioxide and zinc oxide in sunscreens. Canberra: Commonwealth Department of Health and Ageing.

    Google Scholar 

  • Therapeutic Goods Administration. 2006b. Safety of sunscreens containing nanoparticles of zinc oxide or titanium dioxide. Canberra: Commonwealth Department of Health and Ageing.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Diana M Bowman.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Bowman, D.M. Response. Bioethical Inquiry 6, 141–143 (2009). https://doi.org/10.1007/s11673-008-9126-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11673-008-9126-1

Keywords

  • Zinc Oxide
  • Nanoscale Material
  • Therapeutic Good Administration
  • Therapeutic Good
  • Viable Epidermis